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FGF-4Abstract Mesenchymal stem cells (MSCs) were isolated by gradient density centrifugation from
umbilical cord blood. Spindle-shaped adherent cells were permitted to grow to 70% confluence
in primary culture media which was reached by day 12. Induction of differentiation started by cul-
turing cells with differentiation medium containing FGF-4 and HGF. Under hepatogenic condi-
tions few cuboidal cells appeared in culture on day 7. From day 21 to day 28, most of cells
became small and round. The control negative cells cultured in serum free media showed
fibroblast-like morphology. Urea production and protein secretion by the differentiated
hepatocyte-like cells were detected on day 21 and increased on day 28. Protein was significantly
increased in comparison with control by day 28. The cells became positive for AFP at day 7 and
positive cells could still be detected at days 21 and 28. The cells in the control group were stained
negative for AFP. The cells expressed albumin gene at the 14th day that became markedly increased
at the 28th day of culture with HGF and FGF-4. No albumin expression was observed in the 7th
day sample and the control. This study demonstrated that UCB-derived MSCs had the ability to
differentiate into functioning hepatocyte-like cells starting from the 7th day after culturing under
hepatogenic conditions and became well functioning at days 21 and 28. These data indicated that
UCB-derived MSCs can be a promising source of cell therapy for intractable liver diseases.
 2016 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Liver is dedicated to perform an extensive range of tissue speci-
fic functions including intermediary metabolism, detoxification
of drugs or other xenobiotics as well as endogenous substrates,
synthesis of plasma proteins and bile formation.1 The principal, Alex J
2 M.H. Hasan et al.cells of mature liver that carry out these functions are
parenchymal hepatocytes which represent approximately
80% of total hepatic volume.2
Liver dysfunction is a major health problem in the world,
and liver transplantation is the only conventional thriving
treatment of end-stage liver disease.3 Unfortunately, human
donor livers are very limited and are unavailable to most peo-
ple worldwide who necessitate whole organ transplantation.
Hepatocytes transplantation and the use of hepatocytes with
extracorporeal bioartificial liver supports are other alterna-
tives.4 However, the shortage of cell supplies and the long-
term efficiency remains unclear which limits this strategy.3
There are requires for efficient in vitromodels of hepatocytes
developed from other sources with full metabolic function.
Some cell types exhibit the potential to develop into viable hep-
atocytes such as embryonic stem cells (ESCs) and adult stem
cells (ASCs).5 Studies on ESCs were limited in clinical therapeu-
tic applications as a result of ethical controversies. On the other
hand, adult SCs (like bone marrow stem cells) can be propa-
gated in large quantities and remain capable to differentiate into
various tissue types6 including hepatocyte lineage.7
Recently, human umbilical cord blood (HUCB) has been
used as a rich, easily available and ethically acceptable source
of stem cells (SCs). UCB can be collected from donors without
invasive or painful procedure and is rarely infectious.8 UCB-
derived cells are also considered more primitive than BM-
derived cells so they represent a more appropriate source for
cellular therapies.9
There are 2 types of stem cells in HUCB: mesenchymal
(MSCs) and hematopoietic. Lately it has been reported that
UCB mesenchymal progenitor cells are capable of differentiat-
ing into hepatocytes.10 Isolated MSCs from HUCB were
induced to differentiate into hepatocyte-like cells under the
effect of pro-hepatogenic conditions of different cytokines
and growth factors including fibroblast growth factor (FGF)
and hepatocyte growth factor (HGF).10–13 Transformation of
the fibroblast-like cells into round epithelioid cells expressing
mRNAs of albumin (ALB), and alpha-fetoprotein took place
under these hepatogenic conditions 10,11,13. The functional
capacity of the hepatocyte-like cells was assessed by albumin
and urea secretion10,12 and the ability to integrate DiI-
acetylated low-density lipoprotein.10,11
The aim of this work was to study the functional activity of
hepatocyte-like cells derived from HUCB-MSCs at different
time points by reverse transcription–polymerase chain reaction
(RT-PCR) for albumin gene expression level, immunocyto-
chemical stain for detection of alpha-fetoprotein in the cell
cytoplasm and biochemical assay of protein and urea levels
secreted in the culture media.2. Materials and methods
The study protocol was approved by the ethics committee of
the Mansoura University.
2.1. Materials
Dulbecco’s modified Eagle’s medium (DMEM), fetal bovine
serum (FBS), recombinant human fibroblast growth factor
(FGF)-4, penicillin/streptomycin/L-glutamine (100), recombi-Please cite this article in press as: Hasan MH et al. In vitro diﬀerentiation of human u
Med (2016), http://dx.doi.org/10.1016/j.ajme.2016.05.002nant human hepatocyte growth factor (HGF), Ficoll-Paque
(1077), all materials were purchased from Sigma, Egypt.
2.2. Collection of umbilical cord blood
UCB samples (No = 22) were obtained from Department of
Obstetrics and gynecology, Mansoura University Hospital.
Samples were collected after informed consent was given
from full-term elective cesarean sections before placental sep-
aration. Family history of gene disorders and maternal fever
was excluded. The umbilical cord was double clamped two
inches apart from infant’s abdomen, wiped with 70% alcohol
followed by Betadine at needle insertion site to insure steril-
ity. The needle insertion site was just above the clamp. The
blood samples were obtained in special cord blood collection
bags.14
2.3. Mesenchymal stem cell isolation and culture
The collected blood processed within 6 h of collection and the
samples were transported in sterile tubes and diluted with
phosphate buffer saline (PBS) in concentration 1:1. Mesenchy-
mal stem cells were isolated using Ficoll gradient density cen-
trifugation. Ficoll was added to the sample in concentration
3:1. Ficoll-Paque was normally placed at the bottom of a con-
ical tube, and the blood was then slowly layered above it. Cen-
trifugation of the tubes was done at 400 RCF for 30 min. The
supernatant was discarded and the puffy coat layer which con-
tained mononuclear cells was aspirated and transferred into
other tube. PBS was added for washing in concentration 1:1
and centrifuged at 2000 RPM for 5 min. The supernatant
was discarded.
The suspended precipitated cell pellet was cultured in pri-
mary complete culture media (containing 20 ml DMEM –
1% L-glutamine- 10% fetal bovine serum – 1 ml antibiotic)
and plated in tissue culture flasks (25 cm2). The samples were
incubated in incubator (37 C) with 5% CO2 level and were
nourished every 3 days. Feeding step was performed by dis-
carding the old media and adding 20 ml new complete media
as mentioned before.
After culturing cells for 12 days in primary culture media,
cells reached 70–80% confluence. The old media was discarded
and 10 ml trypsin was added to each flask for 5 min. The flasks
were shaken to ensure that the cells were completely detached
from the flask wall, then the content of the flasks was put in
tubes to be centrifuged for 5 min at 2000 RBM. The cell pellets
appeared on the wall of the tube, the supernatant was dis-
carded, finally the cells in the media were transferred into
new flasks (25 cm2) for subculture.15
2.4. Hepatogenic differentiation
To start induction of cell differentiation into hepatocytes,
second- to third-passage cells, at approximately 70% confluence
were treated with differentiation medium consisting of serum
free DMEM supplied with 20 ng/mL HGF, 10 ng/ml FGF4
and 1% antibiotic penicillin and streptomycin 12. Feeding was
carried out two times per week and hepatogenic differentiation
was investigated at different time points (7th -14th -21st -28th
day) after treatment with differentiation medium.mbilical cord blood mesenchymal stem cells into functioning hepatocytes, Alex J
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(RT-PCR) for albumin gene
Extraction of RNA was done from 1  106 MSCs differenti-
ated cells using RNEasy (Sigma) as per the manufacturer’s
instructions. The reverse transcription of mRNA to comple-
mentary DNA was done using Advantage RT-for-PCR
(Sigma) as per the manufacturer’s instructions.
The resulting cDNA was amplified by the use of ABI
GeneAmp PCR System 2400 (Sigma) under the following
conditions: For human albumin gene (50-CTTGAATGT
GCTGATGACAGG, 50 –GC AA GT CA GC AGGCATCT
CATC) amplification: initial denaturation (94 C for 5 min),Figure 1 Human umbilical cord blood derived mesenchymal stem ce
like morphology (black arrow) (1a). Cells in primary culture media at
(1b). After treatment with FGF4 and HGF for 7 days, few rounded ce
cells (white arrow) increased after 14 days of culture under hepatogenic
conditions, many cells were rounded (white arrow) (e). The cells of the
contrast microscope 100.
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2 min) and final extension (72 C for 3 min). For GAPDH
gene (50-GT CTTCTCCACCATGGAGAAGGCT, 50-CA
TG CC AG TGAGCT TC CCGTTCA) amplification: denat-
uration at 95 C for 300 s, annealing (30 cycles at 94 C for
30 s), extension (55 C for 30 s) and final Extension (72 C
for 60 s).
Detection of amplification products: The products of PCR
were subjected to agarose gel electrophoresis using 2% agarose
gel containing 2 lL of 10 mg/1 ml ethidium bromide (Sigma),
using 1 Tris–Borate-EDTA Buffer (TBE Buffer) for one
hour at 70 V.lls (UCB-MSC) in primary culture media on day 4 with fibroblast
day 12 were extensively expanded and overlapped in some areas
lls appeared (white arrow) (1c). The number of cuboidal or round
conditions (d). By day 21 to day 28 of culturing under hepatogenic
control negative group were fibroblast-like (black arrow) (f). Phase
mbilical cord blood mesenchymal stem cells into functioning hepatocytes, Alex J
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different time points
Samples were obtained from cell culture media under hepato-
genic conditions at different time points (7th -14th -21st -28th
day). Serum free medium was used as a negative control. Col-
lection and investigations of samples were done for urea and
protein levels.16
2.7. Immunocytochemical study for alpha fetoprotein (AFP)
Cells were fixed with 95 mL/L ethanol for 10 min at 4 C, and
incubated with blocking solution for 10 min to block endoge-
nous peroxidases. Incubation with the primary antibody
(anti-AFP) was done for 30–60 min at room temperature.
The slides were then incubated with enzyme conjugate fol-
lowed by DAB (Power-Stain TM 1.0 Poly HRP DAB Kit,
Genemed Biotechnologies, Inc.) according to the manufac-
turer’s instructions. The slides were then counterstained with
hematoxylin, dehydrated and mounted. Positive reaction
appeared as brown cytoplasmic stain.
2.8. Statistical analysis
The data of protein and urea assay were expressed as mean
± SD. The statistical software SPSS12.0 was used. The results
were analyzed by t-test. P< 0.05 was considered statistically
significant.Figure 2 The level of urea (mean ± SD) in the culture media
was significantly (*) increased on day 21 and day 28. The control
level showed stability. p< 0.05.
Figure 3 The level of protein (mean ± SD) in the culture media
significantly (*) increased at day 28. The control level showed
stability. p< 0.05.3. Results
3.1. Isolation and culture of MSCs from UCB
Mesenchymal stem cells (MSCs), obtained by gradient density
centrifugation, were heterogeneous during the first few days.
Spindle-shaped cells were observed on the 4th day adherent
to the bottom of culture flasks while many round cells were
floating in the medium. Changing the medium progressively
decreased the floating cells till their disappearance.
3.2. Expansion and hepatogenic differentiation of HUCB-MSC
Human umbilical cord blood derived mesenchymal stem cells
(HUCB-MSC) were permitted to grow to 70% confluence in
primary culture media. After 4 days of culture in primary cul-
ture media, the adhered cells were fibroblast-like and few in
number (Fig. 1a). By day 12, the primary cultured cells reached
a 70–80% confluence and the cells extensively expanded and
overlapped in some areas (Fig 1b).
After that, cells were subcultured and differentiation was
started by culturing cells with differentiation medium contain-
ing FGF-4 and HGF. Under hepatogenic conditions with
FGF4 andHGF, cells did not expose any change comparedwith
the control before the 7th day of treatment. On day 7, few cuboi-
dal or round cells appeared in culture (Fig. 1c). After 14 days,
the number of cuboidal cells increased in the culture (Fig. 1d).
From day 21 to day 28, most of cells became cuboidal or round
(Fig. 1e). The control negative cells cultured in serum free media
containingDMEM, 1%L-glutamine, penicillin (100 U/mL) andPlease cite this article in press as: Hasan MH et al. In vitro diﬀerentiation of human u
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and no round shaped cells were found (Fig. 1f).
3.3. Urea and protein assay
Urea production and protein secretion by the differentiated
hepatocyte-like cells were detected at different time points dur-
ing differentiation. Under hepatogenic conditions by treatment
with FGF-4 and HGF, urea produced by MSCs was signifi-
cantly higher compared to control on day 21 and increased
on day 28 (Fig. 2). Protein was significantly increased in com-
parison with control by day 28 (Fig. 3).
3.4. Immunocytochemistry staining for AFP
After culture with both HGF and FGF-4, the cells were posi-
tive for AFP at different time points 7, 14, 21 and 28. Thembilical cord blood mesenchymal stem cells into functioning hepatocytes, Alex J
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be detected by day 21 and day 28 (Fig. 4a–d). The cells in the
control group were stained negative for AFP (Fig. 4e).
3.5. Gene expression study using reverse transcription
polymerase chain reaction (RT-PCR)
The expression of GAPDH as a control gene did not differ in
between the control and other samples under hepatogenic con-
ditions indicating valid mRNA in all specimens (Fig. 5).
The albumin gene is known as a common hepatogenic mar-
ker. RT-PCR analysis of albumin gene expression showed that
UCB-derived MSCs could express albumin gene in a time-
dependent manner in the differentiating medium containing
FGF-4 and HGF. The analysis revealed progressive increase
in albumin expression from day 14 till day 28 of culture. No
albumin expression was observed in the 7th day sample and
the control specimen (Fig. 5).Figure 4 After 7 days of culturing UCB-MSC under hepatogenic con
cytoplasmic reaction for AFP (arrows) (4a). At day 14 under hepatoge
(arrows) (4b) and some cells were still positive by day 21 (4c) and day 2
undifferentiated cells stained negative for AFP (4e). Immunocytochem
Please cite this article in press as: Hasan MH et al. In vitro diﬀerentiation of human u
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The characterization of stem cells present in adult BM and
UCB has exposed that UCB-derived MSCs are similar to bone
marrow-derived MSCs with respect to cellular properties and
multi-lineage differentiation potential.17–19 However, UCB-
derived MSCs have a low risk of immunoreactivity and can
be isolated without any harm of the baby and no ethical
concerns.8
MSCs should be isolated from UCB sample immediately or
within 6 h of collection20 because the activity and the quantity
of MSCs in HUCB are low and decrease with time. In this
study, MSCs were isolated from 3 out of 22 samples, which
was in accordance with the previous study done by Kang
et al. who isolated MSCs from 10 out of 39 samples.12
In the present study, isolated MSCs from UCB were hetero-
geneous during the first few days. Cells adhering to the bottom
of culture flasks were observed on day 4–5 and were fibroblast-ditions by treatment with FGF-4 and HGF, cells showed positive
nic conditions, almost all cells showed positively stained cytoplasm
8 (4d). Control negative cells cultured in serum free media showed
istry stain for AFP 100.
mbilical cord blood mesenchymal stem cells into functioning hepatocytes, Alex J
Figure 5 A photograph showing reverse transcription poly-
merase chain reaction (RT-PCR) assays for albumin mRNA
which was expressed by hepatocyte-like cells derived from MSC.
The bands indicating the expression of albumin appeared at days
14, 21 and 28. No expression was detected at day 7 of
differentiation, and the control sample. GAPDH mRNA, which
was used as a control gene, was expressed in the 5 specimens (7, 14,
21, 28 days) under hepatogenic conditions and the control
specimen.
6 M.H. Hasan et al.like. The sub-cultured cells were much purer and fibroblast-
like, with disappearance of other cells. According to set of
standards proposed by The International Society for Cellular
Therapy, a cell can be classified as a MSC when having plastic
adherent properties under normal culture conditions and a
fibroblast-like morphology. In fact, some claim that MSCs
and fibroblasts are identical functionally.21 In the present
study the primary culture cells were allowed to grow to 70%
confluence with a density of MSCs 1  106, prior to induction
of differentiation by growth factors. Schwartz et al.5, working
on bone marrow derived progenitor cells, reported that a
higher cell density favored hepatogenesis, whereas densities
less than 12.5  103 failed to give rise to hepatocyte-like cells.
In the previous studies, differentiation of stem cells derived
from UCB or matrix into hepatocytes was induced through
addition of different mixtures of cytokines and growth factors
like fibro-blast growth factor (FGF), hepatocyte growth factor
(HGF), oncostatin M, epidermal growth factor, leukemia inhi-
bitory factor, insulin-transferrin-selenium premix and
others.22,10,23–26
Hepatocyte growth factor (HGF) was first recognized as a
blood-derived mitogen for hepatocytes. HGF and its receptor
c-Met are the key factors for liver growth and function27 and
in helping the proliferation of hepatocytes28 and liver regener-
ation.27 HGF stimulates the proliferation of hepatic progina-
tors to repair hepatic injury.29 Adult human bone marrow
MSCs were induced to differentiate into hepatocytes in vitro
after being cultured with only HGF.30
Fibroblast growth factor-4 (FGF-4) is mitogenic for fibrob-
lasts and endothelial cells. Mouse embryonic stem cells could
differentiate into cells expressing hepatocyte-specific genes andPlease cite this article in press as: Hasan MH et al. In vitro diﬀerentiation of human u
Med (2016), http://dx.doi.org/10.1016/j.ajme.2016.05.002antigens when FGF-4 was added to the culture medium.31
However, Schwartz et al. determined that the two essential
growth factors for proper hepatocyte differentiation are
FGF-4 and HGF.5
This study showed that with the induction of HGF and
FGF-4 the UCB-MSCs could expand in vitro and differentiate
into hepatocyte-like cells. By day 7, some cells started to differ-
entiate by acquiring a cuboidal or round form. At day 14, the
number of differentiated cells increased and expressed albumin
gene as detected by RT-PCR analysis. However, the secretion
of the protein was significantly detected only by the 28th day.
Urea secretion was significantly increased at the 21st day and
elevated further by the 28th day. This indicates that MSCs
started to differentiate as early as the 7th day but started to
function by the 21st day of culture under hepatogenic condi-
tions. These results are closely similar to those of Kang et al.
who used the same hepatogenic induction technique by HGF
and FGF-4.12 However, they noticed earlier secretion of albu-
min (by day 16) detected by radioimmunoassay. They found
also progressive increase in AFP level till day 28. In this study
the AFP immuno-positive cells became less toward the 28th
day. A similar observation has been found in hepatocytes
derived from BM progenitor cells.5 AFP is considered an early
developmental marker of hepatoblasts formation. So, the
decrease of its expression by some cells with time may indicate
more maturation of hepatocyte-like cells.5. Conclusion
This study demonstrated that UCB-derived MSCs had the
ability to differentiate into hepatocyte-like cells starting from
the 7th day after culturing under hepatogenic conditions and
became well functioning at days 21 and 28. These data indi-
cated that UCB-derived MSCs can be a promising source of
cell therapy for intractable liver diseases.Conﬂict of interest
We have no conflict of interest to declare.References
1. Takiguchi M. TheC/EBP family of transcription factors in the
liver and other organs. Int J Exp Pathol 1998;79:369–91.
2. Neuberger J. Liver transplantation. J Hepatol 2000;32:198–207.
3. Kakinuma S, Nakauchi H, Watanabe M. Hepatic stem/progenitor
cells and stem-cell transplantation for the treatment of liver
disease. J Gastroenterol 2009;44:167–72.
4. Jensen J, Hyllner J, Bjo¨rquist P. Human embryonic stem cell
technologies and drug discovery. J Cell Physiol 2009;219:513–9.
5. Schwartz RE, Reyes M, Koodie L, Jiang Y, Blackstad M, Lund T,
et al. Multipotent adult progenitor cells from bone marrow
differentiate into functional hepatocyte-like cells. J Clin Invest
2002;109(10):1291–302.
6. Kuehnle I, Goodell MA. The therapeutic potential of stem cells
from adults. Br Med J 2002;325:372–6.
7. Stieger B, Peters R, Sidler MA, Meier PJ. Hepatocyte transplan-
tation: potential of hepatocyte progenitor cells and bone marrow
derived stem cells. Swiss Med Wkly 2006;136:552–6.
8. Rubinstein P, Rosenfield RE, Adamson JW, Stevens CE. Stored
placental blood for unrelated bone marrow reconstruction. Blood
1993;81:1679–90.mbilical cord blood mesenchymal stem cells into functioning hepatocytes, Alex J
Differentiation of mesenchymal stem cells into functioning hepatocytes 79. Lee MW, Jang IK, Yoo KH, Sung KW, Koo HH. Stem and
progenitor cells in human umbilical cord blood. Int J Hematol
2010;92:45–51.
10. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, Chen TH.
Isolation of multipotent mesenchymal stem cells from umbilical
cord blood. Blood 2004;103:1669–75.
11. Hong SH, Gang EJ, Jeong JA, Ahn C, Hwang SH, Yang IH, et al.
2005 In vitro Differentiation of human umbilical cord blood-
derived mesenchymal stem cells into hepatocyte-like cells. Biochem
Biophys Res Commun 2005;330:1153–61.
12. Kang XQ, Zang WJ, Bao LJ, Li DL, Song TS, Xu XL, et al.
Fibroblast growth factor-4 and hepatocyte growth factor induce
differentiation of human umbilical cord blood-derived mesenchy-
mal stem cells into hepatocytes. World J Gastroenterol 2005;11
(47):7461.
13. Jung YJ, Ryu KH, Cho KA, Woo SY, Seoh JY, Cho SJ, et al. In
vitro hepatic differentiation of human umbilical cord blood and
bone marrow cells. Pediatr Hematol Oncol 2008;25:481–91.
14. Jones J, Stevens CE, Rubinstein P, Robertazzi RR, Kerr A,
Cabbad MF. Obstetric predictors of placental/umbilical cord
blood volume for transplantation. Am J Obstet Gynecol 2003;188
(2):503–9.
15. Secco M, Zucconi E, Vieira NM, Fogac¸a LL, Cerqueira A,
Carvalho MDF, et al. Multipotent stem cells from umbilical cord:
cord is richer than blood! Stem Cells 2008;26(1):146–50.
16. Duen˜as F, Becerra V, Cortes Y, Vidal S, Sa´enz L, Palomino J,
et al. Hepatogenic and neurogenic differentiation of bone marrow
mesenchymal stem cells from abattoir-derived bovine fetuses.
BMC Vet Res 2014;10:154.
17. Panepucci RA, Siufi JL, Silva WA, Proto-Siquiera R, Neder L,
Orellana M, et al. Comparison of gene expression of umbilical
cord vein and bone marrow-derived mesenchymal stem cells. Stem
Cells 2004;22:1263–78.
18. Feldmann RE, Bieback K, Maurer MH, Kalenka A, Bu¨rgers HF,
Gross B, et al. Stem cell proteomes: a profile of human
mesenchymal stem cells derived from umbilical cord blood.
Electrophoresis 2005;26(14):2749–58.
19. Jeong JA, Hong SH, Gang EJ, Ahn CH, wang SH, Yang IH, et al.
Differential gene expression profiling of human umbilica lcord
blood-derived mesenchymal stem cells by DNA microarray. Stem
Cells 2005;23:584–93.
20. Lu LL, Liu YJ, Yang SG, Zhao QJ, Wang X, Gong W, et al.
Isolation and characterization of human umbilical cord mesenchy-Please cite this article in press as: Hasan MH et al. In vitro diﬀerentiation of human u
Med (2016), http://dx.doi.org/10.1016/j.ajme.2016.05.002mal stem cells with hematopoiesis-supportive function and other
potentials. Haematologica 2006;91:1017–26.
21. Hematti P. Mesenchymal stromal cells and fibroblasts: a case of
mistaken identity? Cyto Therapy 2012;14(5):516–21.
22. Kakinuma S, Tanaka Y, Chinzei R, Watanabe M, Shimizu-Saito
Y, Hara Y, et al. Human umbilical cord blood as a source of
transplantable hepatic progenitor cells. Stem Cells 2003;21:217–27.
23. Lee OK, Kuo TK, Chen W, Lee K, Hsieh S, Chen T. Isolation of
multipotent mesenchymal stem cells from umbilical cord blood.
Blood 2004;103(5):1669–75.
24. Campard D, Lysy PA, Najimi M, Sokal EM. Native umbilical
cord matrix stem cells express hepatic markers and differentiate
into hepatocyte-like cells. Gastroenterology 2008;134(3):833–48.
25. Moon YJ, Lee MW, Yoon HH, Yang MS, Jang IK, Lee JE, et al.
Hepatic differentiation of cord blood-derived multipotent progen-
itor cells (MPCs) in vitro. Cell Biol Int 2008;32(10):1293–301.
26. Sellamuthu S, Manikandan R, Thiagarajan R, Babu G, Dinesh D,
Prabhu D, Arulvasu C. In vitro trans-differentiation of human
umbilical cord derived hematopoietic stem cells into hepatocyte
like cells using combination of growth factors for cell based
therapy. Cytotechnology 2011;63:259–68.
27. Matsumoto K, Nakamura T. Hepatocyte growth factor: molec-
ular structure and implications for a central role in liver
regeneration. J Gastroenterol Hepatol 1991;6:509–19.
28. Fujiwara K, Nagoshi S, Ohno A, Hirata K, Ohta Y, Mochida S,
et al. Stimulation of liver growth by exogenous human hepatocyte
growth factor in normal and partially hepatectomized rats.
Hepatology 1993;18(6):1443–9.
29. Hasuike S, Ido A, Uto H, Moriuchi A, Tahara Numata M, et al.
Hepatocyte growth factor accelerates the proliferation of hepatic
oval cells and possibly promotes the differentiation in a acetyl
amino fluorene/partial hepatectomy model in rats. J Gastroenterol
Hepatol 2005;20:1753–61.
30. Fiegel HC, Lioznov MV, Cortes-Dericks L, Lange C, Kluth D,
Fehse B, et al. Liver-specific gene expression in cultured human
hematopoietic stem cells. Stem Cells 2003;21:98–104.
31. Ruhnke M, Ungefroren H, Zehle G, Bader M, Kremer B,
Fa¨ndrich F. Long-term culture and differentiation of rat embry-
onic stem cell-like cells in to neuronal, glial, endothelial, and
hepatic lineages. Stem Cells 2003;21:428–36.mbilical cord blood mesenchymal stem cells into functioning hepatocytes, Alex J
